>
pdufa.bio

MK-8527

Updated ยทnext FDA decision on the calendar

MK-8527 is a Merck & Co., Inc. program. Its next catalyst is a Readout in Oct 2027. Every date links its source.

MRK catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Merck & Co., Inc. (MRK). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Oct 2027MRK

Questions

When is MK-8527's next FDA decision or readout?

The next tracked catalyst for MK-8527 is a Readout in Oct 2027.

What happened at MK-8527's most recent FDA decision?

No FDA decision for MK-8527 is in our archive yet.

Who makes MK-8527?

Merck & Co., Inc. (MRK).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.